Medicare Enrolled

Dr. Rita Raturi, MD

Rheumatology · Zephyrhills, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
38051 MARKET SQUARE DR STE 220, Zephyrhills, FL 33542
8137821234
Registered in NPPES since 2014
NPI: 1285052852 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raturi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raturi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Raturi

Dr. Rita Raturi is a rheumatology specialist in Zephyrhills, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Raturi performed 4,432 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Raturi received a total of $16,972 from 42 pharmaceutical and/or device companies across 875 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Raturi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ 4,432 Medicare services $16,972 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 131241 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
4,432
Medicare services
Bottom 48% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,520 $17 $24
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
1,475 $32 $43
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
145 $59 $98
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
105 $54 $76
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
66 $96 $137
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $93 $139
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
38 $103 $182
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
37 $3 $3
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
34.8% high complexity
59.2% medium
6.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,972
Total received (2018-2024)
Avg $2,425/year across 7 years
Top 29% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
875
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,476
2023
$3,260
2022
$3,124
2021
$3,434
2020
$2,040
2019
$914
2018
$724

Payments by company (2024)

Amgen Inc.
$584
ANI Pharmaceuticals, Inc.
$481
Janssen Biotech, Inc.
$471
Novartis Pharmaceuticals Corporation
$237
PFIZER INC.
$220
ABBVIE INC.
$206
UCB, Inc.
$163
AstraZeneca Pharmaceuticals LP
$162
GlaxoSmithKline, LLC.
$144
Lilly USA, LLC
$141
Mallinckrodt Hospital Products Inc.
$132
Sandoz Inc.
$112
Radius Health, Inc.
$68
Kiniksa Pharmaceuticals International, plc
$59
Aurinia Pharma U.S., Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Bioventus LLC
$44
SOBI, INC
$44
Alexion Pharmaceuticals, Inc.
$36
SCILEX PHARMACEUTICALS INC.
$30
Kyowa Kirin, Inc.
$20
Almatica Pharma LLC
$18
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,616
Janssen Biotech, Inc.
$1,825
UCB, Inc.
$1,388
PFIZER INC.
$1,129
Novartis Pharmaceuticals Corporation
$1,129
GlaxoSmithKline, LLC.
$873
Horizon Therapeutics plc
$871
ABBVIE INC.
$659
Lilly USA, LLC
$651
Alexion Pharmaceuticals, Inc.
$573
AstraZeneca Pharmaceuticals LP
$568
ANI Pharmaceuticals, Inc.
$550
Boehringer Ingelheim Pharmaceuticals, Inc.
$472
Genentech USA, Inc.
$465
GENZYME CORPORATION
$423
Aurinia Pharma U.S., Inc.
$372
E.R. Squibb & Sons, L.L.C.
$295
AbbVie Inc.
$250
Janssen Scientific Affairs, LLC
$232
Celgene Corporation
$231
Sobi, Inc
$181
Mallinckrodt Hospital Products Inc.
$159
SOBI, INC
$141
Sandoz Inc.
$139
AbbVie, Inc.
$137
Radius Health, Inc.
$116
Fresenius Kabi USA, LLC
$68
Organon LLC
$65
Bioventus LLC
$59
Kiniksa Pharmaceuticals International, plc
$59
Actelion Pharmaceuticals US, Inc.
$36
SCILEX PHARMACEUTICALS INC.
$30
Merck Sharp & Dohme Corporation
$30
TerSera Therapeutics LLC
$27
Antares Pharma, Inc.
$25
Hikma Pharmaceuticals USA
$22
Kyowa Kirin, Inc.
$20
Zimmer Biomet Holdings, Inc.
$19
Flexion Therapeutics, Inc.
$18
Almatica Pharma LLC
$18
Ultragenyx Pharmaceutical Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Crysvita · DUROLANE · Durolane · EVENITY · EVUSHELD · Enbrel · Gel-One Cross-linked Hyaluronate · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · OTREXUP · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Soliris · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UBRELVY · XELJANZ · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Zephyrhills?
Compare rheumatologists in the Zephyrhills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
33
County median income
$67,384
Nearest hospital to ZIP centroid (approximate)
Adventhealth Zephyrhills
2.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Raturi is a mixed practice specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Raturi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Raturi performed 2,520 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Raturi receive payments from pharmaceutical companies?
Yes. Dr. Raturi received a total of $16,972 from 42 companies across 875 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raturi's costs compare to other rheumatologists in Zephyrhills?
Dr. Raturi's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raturi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →